🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This study is being done to assess the safety and tolerance of different do...
Status
Completed
Location
Service Des Maladies Du Sang
Start Date
2004-03
Trial ID
NCT00596804
Treatments Being Tested
This is a multi-national, multi-centre, placebo-controlled, double-blind, r...
Status
Terminated
Location
Nycomed Investigational Site
Start Date
2011-08
Trial ID
NCT01390545
Treatments Being Tested
A phase I dose escalation study of veltuzumab and milatuzumab in relapsed a...
Status
Completed
Location
Ohio State University Comprehensive Cancer Center
Start Date
2009-09
Trial ID
NCT00989586
This trial will study different dose levels of hA20 (IMMU-106) to see if th...
Status
Terminated
Location
University of Southern California- Keck School of Medicine
Start Date
2007-11
Trial ID
NCT00547066
Treatments Being Tested
This is a Phase I trial to look at safety and how a patient's body will tol...
Status
Completed
Location
New York Presbyterian Hospital/Cornell Medical Center
Start Date
2004-09
Trial ID
NCT00285428
Treatments Being Tested
The goal of this study is to evaluate a new approach to immunotherapy in NH...
Status
Withdrawn
Location
Helen F. Graham Cancer Center
Start Date
2010-05
Trial ID
NCT01101581
Treatments Being Tested
The purpose of this study is to determine if a subcutaneous (SC) dosing sch...
Status
Completed
Location
Lewis Cancer Center and Research Pavilion
Start Date
2008-01
Trial ID
NCT00546793
Treatments Being Tested
The treatment of adult B-cell acute lymphoblastic leukaemia (ALL) has progr...
Status
Unknown
Location
University Hospitals Birmingham NHS Foundation
Start Date
2010-01
Trial ID
NCT01279707
A Phase I/II clinical trial using a fractionated dosing regimen of 90Y-epra...
Status
Terminated
Location
Weill Cornell Medical College
Start Date
2010-10
Trial ID
NCT01147393
Treatments Being Tested